Skip to content
SummitGrid provides cutting-edge energy management and grid…

Zimbabwe Rejects ‘Lopsided’ American Healthcare Assistance Package Over Data Fears

Health aid image
The offered US funding would have supported programmes for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has turned down a substantial American health deal worth $367m (272 million pounds) over five years over Washington's demand for confidential data.

The decision was revealed after a official document from December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the deal was "unbalanced".

A government representative later stated that the United States was demanding access to genetic material for research and profit while was not willing to share the resulting advantages from any future medical innovations.

"We are forced to start the difficult and regrettable task of ending our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the US had furnished over $1.9bn as health assistance to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has called for continued negotiations to find a deal acceptable to both sides so the country's vital HIV programme can continue.

Broader Background

This development follows a similar situation in neighbouring Kenya, where a high court suspended a similar health funding agreement after legal challenges were filed about the security of citizens' health data.

Since returning to office last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).

The agency had overseen assistance for the American government, but Trump argued its spending was "wasteful" and his government was pursuing government-to-government agreements to enhance openness and accountability.

According to reports, Sixteen African countries have to date agreed to these new agreements, representing over $18.3bn in committed funds.

Details of the Declined Deal

The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this cooperation might have yielded significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on antiretroviral therapy through American-funded initiatives," Tremont commented.

However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".

"Zimbabwe was being asked to provide its genetic material and health information over an extended period, with no equivalent guarantee of benefiting from any medical innovations – like new medicines or tests – that could result from that shared data," his statement read.

"In essence, our country would supply the basic resources for scientific discovery without any certainty that the end products would be available to our population should a new health crisis arise."

Sovereignty and International Frameworks

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting structures already set up via the global health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing framework designed to deal with future global health emergencies.

"This mechanism is designed to guarantee that when a nation provides its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to create them."

These objections over the US deal "are not meant as opposition to America," Mangwana stressed.

"We welcome ongoing dialogue with our US partners on how future collaboration might be designed in a manner that respects the independence and dignity of each country."

Health Experts Reaction

A leading public health body said it understood the official position, but urged that talks should continue given that much of the nation's HIV programmes depended on international support.

"In cases where specific concerns arise, such as those involving data governance or agreement terms, these can frequently be resolved through technical clarification and negotiated safeguards," it commented.

This impasse emphasises the ongoing tensions between receiving crucial foreign assistance and protecting a country's data in an ever more data-driven world.

Written by

Vanessa Andrews

Renewable energy expert with over a decade of experience in grid technology and sustainable infrastructure development.

SummitGrid

Type to search articles.